Shasank Rijal is a Cardiology physician. OpenAlex indexes 17 publications with 391 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- HEARTFLOW, INC.Program year20251 payment
- GE HEALTHCAREProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.1%Beta blocker22.7%Metoprolol Succinate81%Metoprolol Tartrate9%Carvedilol5%Atenolol3%Sotalol2%Part D<11 patientsStatin17%Atorvastatin Calcium57%Rosuvastatin Calcium44%Part D≥94 patients+ 12 more classes in this area
Blood & clotting
11.7%P2Y12 inhibitor7.3%Clopidogrel84%Prasugrel Hcl16%Part D<11 patientsFactor Xa inhibitor3%Eliquis100%Part D≥31 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.2%Potassium supplement2.8%Potassium Chloride100%Part D≥29 patientsProton pump inhibitor2.1%Pantoprazole Sodium100%Part D≥26 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Implantable Defibrillator Therapy in Cardiac Arrest Survivors With a Reversible Cause
Circulation Arrhythmia and Electrophysiology
2018 - Antithrombotic Therapy in Nonvalvular Atrial Fibrillation: Consensus and Challenges
The American Journal of the Medical Sciences
2018 - Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis
Journal of Cardiovascular Magnetic Resonance
2016 - Lead related complications in quadripolar versus bipolar left ventricular leads
Indian Pacing and Electrophysiology Journal
2016 - Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator
Journal of Cardiovascular Electrophysiology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”